This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, J.-B. Articles by Simpson, L. L. Search for Related Content PubMed PubMed Citation Articles by Park, J.-B. Articles by Simpson, L. L.

Inhalational Poisoning by Botulinum Toxin and Inhalation Vaccination with Its Heavy-Chain Component

Department of Medicine,¹ Department of Biochemistry and Molecular Pharmacology, Jefferson Medical College, Philadelphia, Pennsylvania²

Received 29 July 2002/ Returned for modification 18 October 2002/ Accepted 26 November 2002

Botulinum toxin is the etiologic agent responsible for the disease botulism, which is characterized by peripheral neuromuscular blockade. Botulism is ordinarily encountered as a form of oral poisoning. The toxin is absorbed from the lumen of the gut to reach the general circulation and is then distributed to peripheral cholinergic nerve endings. However, there is a widespread presumption that botulinum toxin can also act as an inhalation poison, which would require that it be absorbed from the airway. Experiments have been done to show that both pure toxin and progenitor toxin (a complex with auxiliary proteins) are inhalation poisons. Interestingly, the data indicate that auxiliary proteins are not necessary to protect the toxin or to facilitate its absorption. When studied on rat primary alveolar epithelial cells or on immortalized human pulmonary adenocarcinoma (Calu-3) cells, botulinum toxin displayed both specific binding and transcytosis. The rate of transport was greater in the apical-to-basolateral direction than in the basolateral-to-apical direction. Transcytosis was energy dependent, and it was blocked by serotype-specific antibody. The results demonstrated that the holotoxin was not essential for the process of binding and transcytosis. Both in vivo and in vitro experiments showed that the heavy-chain component of the toxin was transported across epithelial monolayers, which indicates that the structural determinants governing binding and transcytosis are found in this fragment. The heavy chain was not toxic, and therefore it was tested for utility as an inhalation vaccine against the parent molecule. This fragment was shown to evoke complete protection against toxin doses of at least 10⁴ times the 50% lethal dose.

Editor: J. T. Barbieri

This article has been cited by other articles:

• Dembek, Z. F., Smith, L. A., Rusnak, J. M. (2007). Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities. dmphp 1: 122-134 [Abstract] [Full Text]  
• Ravichandran, E., Al-Saleem, F. H., Ancharski, D. M., Elias, M. D., Singh, A. K., Shamim, M., Gong, Y., Simpson, L. L. (2007). Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal Route. Infect. Immun. 75: 3043-3054 [Abstract] [Full Text]  
• Ravichandran, E., Gong, Y., Saleem, F. H. A., Ancharski, D. M., Joshi, S. G., Simpson, L. L. (2006). An Initial Assessment of the Systemic Pharmacokinetics of Botulinum Toxin. J. Pharmacol. Exp. Ther. 318: 1343-1351 [Abstract] [Full Text]  
• Kobayashi, R., Kohda, T., Kataoka, K., Ihara, H., Kozaki, S., Pascual, D. W., Staats, H. F., Kiyono, H., McGhee, J. R., Fujihashi, K. (2005). A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism. J. Immunol. 174: 2190-2195 [Abstract] [Full Text]  
• Ishida, H., Zhang, X., Erickson, K., Ray, P. (2004). Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells. J. Pharmacol. Exp. Ther. 310: 881-889 [Abstract] [Full Text]  
• Maksymowych, A. B., Simpson, L. L. (2004). Structural Features of the Botulinum Neurotoxin Molecule That Govern Binding and Transcytosis across Polarized Human Intestinal Epithelial Cells. J. Pharmacol. Exp. Ther. 310: 633-641 [Abstract] [Full Text]